Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The precision of hippocampal representations predicts incremental value-learning across the adult lifespan.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Features predicting data exclusion in imaging studies of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Reply: Cerebrovascular contributions to the 'vulnerable' medial temporal lobe T-N phenotype.

Brain : a journal of neurology·2026
Same author

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Acta neuropathologica·2026
Same author

Characterizing the MRI signature of hippocampal sclerosis of aging.

Alzheimer's research & therapy·2026
Same author

Cortical thickness in perirhinal area BA35 predicts adaptive episodic memory-guided decision making in older adults.

The journals of gerontology. Series B, Psychological sciences and social sciences·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Amanda Annettesdotter1, Nicola Spotorno2, Anika Wuestefeld2

  • 1Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

粉样阴性轻度认知障碍 (aMCI) 的认知衰退是由基线认知和大脑缩预测的. 这些发现有助于理解像LATE和PART这样的疾病,与阿尔茨海默病不同.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 神经学 神经学
  • 生物标志物 生物标志物

背景情况:

  • 显著的一部分无记忆性轻度认知障碍 (aMCI) 患者缺乏粉样蛋白-β (Aβ) 生物标志物,这表明除了阿尔茨海默病 (AD) 之外还有其他疾病.
  • 在Aβ阴性 (Aβ-) aMCI中,认知衰退的潜在原因包括边缘主导的与年龄相关的TDP-43脑病变 (LATE),脑血管疾病和初级与年龄相关的病 (PART).
  • 对于Aβ-aMCI的预后不确定性,需要确定认知衰退和痴呆症进展的预测因素.

研究的目的:

  • 确定Aβ-aMCI患者认知衰退的人口,认知,流体和成像生物标志物预测因素.
  • 在这个特定的患者群体中开发认知衰退和痴呆症进展的预测模型.
  • 在Aβ-aMCI中区分预后因素,可能与LATE和PART病理有关.

主要方法:

  • 分析了140名Aβ-aMCI患者 (BioFINDER-1/2) 的纵向数据,使用迷你精神状态检查 (MMSE) 和临床痴呆症评分盒 (CDR-SB) 评估认知衰退.
  • 预测因素包括基线认知,脑脊液 (CSF) Aβ42/40,p-tau181,区域性大脑缩 (杏仁体,额头,脑内皮层),全脑皮层厚度和白质超强度.
  • 线性混合效应模型和模型选择 (AIC) 用于确定认知衰退和痴呆症进展的最节的预测模型.

主要成果:

  • 对于MMSE下降,最好的模型包括基线MMSE和全脑皮质厚度.
  • 对于CDR-SB下降,预测因素是基线CDR-SB,杏仁体体积和中额头环皮层厚度.
  • 进展到痴呆的最佳预测是MMSE,侧腔室体积,脑内皮层和全脑皮层厚度,性别和CSF Aβ42/40.

结论:

  • 基线认知状态和全球/区域大脑缩是Aβ-aMCI认知衰退的重要预测因素.
  • 区域大脑测量为特定的潜在病理提供了洞察力,与新的LATE临床标准相关.
  • 发现需要在更大的队列中进行验证,例如阿尔茨海默氏症神经成像计划 (ADNI).